CADOn©: An integrated toolkit for evaluating radiation therapy related changes in the prostate using multiparametric MRI. Viswanath, S., Tiwari, P., Chappelow, J., Toth, R., Kurhanewicz, J., & Madabhushi, A. In Proceedings - International Symposium on Biomedical Imaging, 2011.
doi  abstract   bibtex   
The use of multi-parametric Magnetic Resonance Imaging (T2-weighted, MR Spectroscopy (MRS), Diffusion-weighted (DWI)) has recently shown great promise for diagnosing and staging prostate cancer (CaP) in vivo. Such imaging has also been utilized for evaluating the early effects of radiotherapy (RT) (e.g. intensity-modulated radiation therapy (IMRT), proton beam therapy, brachytherapy) in the prostate with the overarching goal being to successfully predict short- and long-term patient outcome. Qualitative examination of post-RT changes in the prostate using MRI is subject to high inter- and intra-observer variability. Consequently, there is a clear need for quantitative image segmentation, registration, and classification tools for assessing RT changes via multi-parametric MRI to identify (a) residual disease, and (b) new foci of cancer (local recurrence) within the prostate. In this paper, we present a computerized image segmentation, registration, and classification toolkit called CADOnc , and leverage it for evaluating (a) spatial extent of disease pre-RT, and (b) post-RT related changes within the prostate. We demonstrate the applicability of CADOnc in studying IMRT-related changes using a cohort of 7 multi-parametric (T2w, MRS, DWI) prostate MRI patient datasets. First, the different MRI protocols from pre- and post-IMRT MRI scans are affinely registered (accounting for gland shrinkage), followed by automated segmentation of the prostate capsule using an active shape model. A number of feature extraction schemes are then applied to extract multiple textural, metabolic, and functional MRI attributes on a per-voxel basis. An AUC of 0.7132 was achieved for automated detection of CaP on pre-IMRT MRI (via integration of T2w, DWI, MRS features); evaluated on a per-voxel basis against radiologist-derived annotations. CADOnc also successfully identified a total of 40 out of 46 areas where disease-related changes (both absence and recurrence) occurred post-IMRT, based on changes in the expression of quantitative MR imaging biomarkers. CADOnc thus provides an integrated platform of quantitative analysis tools to evaluate treatment response in vivo, based on multi-parametric MRI data. © 2011 IEEE.
@inproceedings{
 title = {CADOn©: An integrated toolkit for evaluating radiation therapy related changes in the prostate using multiparametric MRI},
 type = {inproceedings},
 year = {2011},
 id = {3a0494c6-c7f9-3a32-bcab-e93a5cae3816},
 created = {2023-10-25T08:56:40.803Z},
 file_attached = {false},
 profile_id = {eaba325f-653b-3ee2-b960-0abd5146933e},
 last_modified = {2023-10-25T08:56:40.803Z},
 read = {false},
 starred = {false},
 authored = {true},
 confirmed = {false},
 hidden = {false},
 private_publication = {true},
 abstract = {The use of multi-parametric Magnetic Resonance Imaging (T2-weighted, MR Spectroscopy (MRS), Diffusion-weighted (DWI)) has recently shown great promise for diagnosing and staging prostate cancer (CaP) in vivo. Such imaging has also been utilized for evaluating the early effects of radiotherapy (RT) (e.g. intensity-modulated radiation therapy (IMRT), proton beam therapy, brachytherapy) in the prostate with the overarching goal being to successfully predict short- and long-term patient outcome. Qualitative examination of post-RT changes in the prostate using MRI is subject to high inter- and intra-observer variability. Consequently, there is a clear need for quantitative image segmentation, registration, and classification tools for assessing RT changes via multi-parametric MRI to identify (a) residual disease, and (b) new foci of cancer (local recurrence) within the prostate. In this paper, we present a computerized image segmentation, registration, and classification toolkit called CADOnc , and leverage it for evaluating (a) spatial extent of disease pre-RT, and (b) post-RT related changes within the prostate. We demonstrate the applicability of CADOnc in studying IMRT-related changes using a cohort of 7 multi-parametric (T2w, MRS, DWI) prostate MRI patient datasets. First, the different MRI protocols from pre- and post-IMRT MRI scans are affinely registered (accounting for gland shrinkage), followed by automated segmentation of the prostate capsule using an active shape model. A number of feature extraction schemes are then applied to extract multiple textural, metabolic, and functional MRI attributes on a per-voxel basis. An AUC of 0.7132 was achieved for automated detection of CaP on pre-IMRT MRI (via integration of T2w, DWI, MRS features); evaluated on a per-voxel basis against radiologist-derived annotations. CADOnc also successfully identified a total of 40 out of 46 areas where disease-related changes (both absence and recurrence) occurred post-IMRT, based on changes in the expression of quantitative MR imaging biomarkers. CADOnc thus provides an integrated platform of quantitative analysis tools to evaluate treatment response in vivo, based on multi-parametric MRI data. © 2011 IEEE.},
 bibtype = {inproceedings},
 author = {Viswanath, S. and Tiwari, P. and Chappelow, J. and Toth, R. and Kurhanewicz, J. and Madabhushi, A.},
 doi = {10.1109/ISBI.2011.5872825},
 booktitle = {Proceedings - International Symposium on Biomedical Imaging}
}

Downloads: 0